With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Small Molecule Inhibitors of ERG for Pediatric Leukemia and Sarcoma||University of Virginia, School of Medicine / John Bushweller, PhD||Innovation Grants||2015||Virginia|
|Identifying Mechanisms of Glucocorticoid Resistance in Pediatric Acute Lymphoblastic||University of Massachusetts Medical School / Michelle Kelliher, PhD||Innovation Grants||2015||Massachusetts|
|Regulation of Tumor Debris Mediated Inflammation as a Therapeutic Modality in Medulloblastoma||Dana-Farber Cancer Institute / Mark Kieran, MD, PhD & Dipak Panigrahy, MD||Innovation Grants||2015||Massachusetts|
|Enhancing Effectiveness of Immune Checkpoint Therapy in Neuroblastoma||Children's Hospital Los Angeles / Shahab Asgharzadeh, MD||Innovation Grants||2015||California|
|Histone H3.3 Targeted Therapy for Pediatric High-grade Gliomas||University of California, Davis Medical Center / Paul Knoepfler, PhD||Innovation Grants||2015||California|
|Synergistic Differentiation Therapy in Neuroblastoma||Duke University / Gerard Blobe, M.D./Ph.D||Innovation Grants||2015||North Carolina|
|In Vivo Analysis of Early Neuroblastoma Development using Transgenic Quail||Stowers Institute for Medical Research / Paul Kulesa, PhD||Innovation Grants||2015||Missouri|
|Transcriptional Effectors of Activated RAS Signaling in Juvenile Myelomonocytic Leukemia||Boston Children's Hospital / Alan Cantor, MD, PhD||Innovation Grants||2015||Massachusetts|
|The Effect of Locus of Care Upon Adolescent and Young Adults Cancer Outcomes: An IMPACT Cohort Study||Hospital for Sick Children / Sumit Gupta, MD, PhD||Young Investigator Grants||2015||Ontario|
|A Translational Approach to Identify Drugs with Specific Activity Against EZH2 Mutant High Risk T-ALLs and ETP ALLs that Overexpress the JDP2 bZIP Transcription Factor||Dana-Farber Cancer Institute / Shuning He, PhD||Young Investigator Grants||2015||Massachusetts|